1. 3346 BeyPro1: a Phase II single-arm study for the treatment after recurrence of advanced melanoma patients harboring the V600BRAF mutation and pretreated with Vemurafenib, with the association of Vemurafenib plus Fotemustine. (September 2015) Authors: Queirolo, P.; Spagnolo, F.; Picasso, V.; Simeone, E.; Grimaldi, A.M.; Curvietto, M.; Giorello, L.; Fontana, V.; Merlo, D.F.; Ascierto, P.A.; Bruzzi, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1392: The abscopal effect:efficacy of radiotherapy in patients on progression after ipilimumab 3 mg/kg. (April 2016) Authors: Grimaldi, A.M.; Ascierto, P.A.; Simeone, E.; Giannarelli, D.; Falivene, S.; Borzillo, V.; Giugliano, F.; Sandomenico, F.; Petrillo, A.; Curvietto, M.; Esposito, A.; Paone, M.; Palla, M.; Palmieri, G.; Caraco, C.; Ciliberto, G.; Mozzillo, N.; Muto, P. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗